Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity.
about
Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouseRelationships between Rodent White Adipose Fat Pads and Human White Adipose Fat DepotsDevelopments in our understanding of the effects of growth hormone on white adipose tissue from mice: implications to the clinic.Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropesReduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance.Lack of association between body mass index and plasma adiponectin levels in healthy adults.Growth hormone and adipose tissue: beyond the adipocyte.Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factorAdipocytokines: The pied pipers.GH Receptor Deficiency in Ecuadorian Adults Is Associated With Obesity and Enhanced Insulin SensitivityGH and IGF1: roles in energy metabolism of long-living GH mutant miceThe intricate role of growth hormone in metabolism.Adiponectin in mice with altered GH action: links to insulin sensitivity and longevity?Somatotropic signaling: trade-offs between growth, reproductive development, and longevityClinical challenges in the management of isolated GH deficiency type IA in adulthood.Impact of Growth Hormone on Regulation of Adipose Tissue.Growth Hormone's Effect on Adipose Tissue: Quality versus Quantity.Lifetime congenital isolated GH deficiency does not protect from the development of diabetes.Reduced high-molecular-weight adiponectin is an independent risk factor for cardiovascular lesions in hypercholesterolaemic patients.Chronic liquid nutrition intake induces obesity and considerable but reversible metabolic alterations in Wistar rats.Subjects with isolated GH deficiency due to a null GHRHR mutation eat proportionally more, but healthier than controls.
P2860
Q24613998-200DE744-954C-4880-9538-85C8A4DBE1FCQ26752318-A79B9C57-C206-4C00-BA51-1C7CF66B4F62Q33580161-B4BDDAE1-ECC5-4BBE-B054-7FBA5F5938AEQ33808533-EEF98CBF-4C93-44B0-BA94-AF07327EFDA7Q33998524-BBB2034B-EA23-4693-A953-E6E3B282E0D0Q34167803-79A43D8E-2687-437D-B083-9C28445D78FFQ35038048-BE3ACCFF-F2C0-4581-A28C-7684CF2058AAQ35038082-46A13FAF-7D0F-4B66-AD2E-4A7C2A42E2F5Q35125469-F25DC953-DFD6-4B4F-A12F-00A2C5CFA0D2Q35813235-13A032D6-9856-4AC4-808A-2A4C9D592CF5Q35947436-8B64B3EF-47F7-4BC2-A19F-1AC608CCB503Q35971819-63793506-8D60-4287-AB7C-37A5EC6B7456Q37131355-6103CB3B-7CB3-4DF2-A362-AB12D93A2454Q37158512-AD6F1BF7-B650-4B73-B639-F6C6F1A49A9DQ37662259-6793F271-6343-4D4B-A700-0F5A1C1AF42FQ39390983-BFFC9CEE-E883-4B83-9DEF-F96A4CC34BBBQ41573026-A4947C98-F614-42DF-B0D4-43A508FE18CEQ41776005-27309FBF-B708-4AB6-8513-17AF6174B696Q43504116-603424B8-C8DA-4891-8A23-E8FBCECF359CQ50529797-A8CCF2C7-2D7F-420E-B422-F2F10968456AQ50894498-817D9DC4-C4CD-4232-9FB5-9DF39ECFA1BD
P2860
Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Total and high molecular weigh ...... ndrome despite marked obesity.
@en
Total and high molecular weigh ...... ndrome despite marked obesity.
@nl
type
label
Total and high molecular weigh ...... ndrome despite marked obesity.
@en
Total and high molecular weigh ...... ndrome despite marked obesity.
@nl
prefLabel
Total and high molecular weigh ...... ndrome despite marked obesity.
@en
Total and high molecular weigh ...... ndrome despite marked obesity.
@nl
P2093
P356
P1476
Total and high molecular weigh ...... ndrome despite marked obesity.
@en
P2093
Clara Pariente
Ehud Barhod
Eleanor Yissachar
Hannah Kanety
Shira Ginsberg
Tohru Funahashi
P304
P356
10.1530/EJE-09-0419
P50
P577
2009-09-15T00:00:00Z